CardiaX Intelligence
Platform Evidence Blog About Request Demo

Terms of Use

Last updated: January 2026

These Terms of Use govern your access to and use of the CardiaX Intelligence website at cardiax-os.polsia.app. By accessing this website, you agree to these terms.

Informational Use Only

This website provides general information about CardiaX Intelligence products and services. Nothing on this website constitutes medical advice, clinical guidance, or a solicitation to use any medical device or software in clinical practice without appropriate regulatory review in your jurisdiction.

Not Medical Advice

CardiaX Intelligence is a B2B technology platform. The information on this website is intended for healthcare professionals and hospital administrators evaluating AI diagnostic technology. It is not intended for patients and does not constitute medical advice. Always consult a qualified physician for medical decisions.

Regulatory Notices

Regulatory clearance status varies by modality, jurisdiction, and jurisdiction-specific approval. The regulatory information presented on this website reflects the status known at the time of last update and may not reflect current status in all jurisdictions. Verify regulatory status before clinical deployment.

  • ECGio (HEARTio): INVESTIGATIONAL — NOT FOR SALE IN THE US. Not FDA-cleared.
  • CaRi-Heart® (Caristo): CE-marked in the EU; US FDA clearance anticipated 2026. Not currently FDA-cleared for CaRi-Heart®.
  • All other referenced modalities: FDA 510(k) cleared as described. Verify clearance details before clinical use.

Intellectual Property

The content, design, and materials on this website are the property of CardiaX Intelligence LLC or its licensors. You may not reproduce, distribute, or create derivative works without written permission.

Limitation of Liability

CardiaX Intelligence LLC provides this website on an "as-is" basis. We make no warranties regarding accuracy, completeness, or fitness for any particular purpose. We are not liable for any damages arising from your use of this website.

Governing Law

These terms are governed by the laws of the State of Washington, without regard to conflict of law principles.

Contact

CardiaX Intelligence LLC
14205 SE 36th St Ste 100
Bellevue, WA 98006
nathan.qin@cardiaxintelligence.com

CardiaX Intelligence

Orchestrating AI-powered cardiac diagnosis across 6 modalities — from a single hospital integration.

CardiaX Intelligence LLC
14205 SE 36th St Ste 100
Bellevue, WA 98006

Platform

  • 6 Modalities
  • Clinical Evidence
  • Hospital IT
  • How It Works
  • Request Demo

Company

  • About
  • Blog
  • FAQ
  • Contact

Legal

  • Privacy Policy
  • Terms of Use

Intended Use: CardiaX Intelligence is a software platform that integrates FDA-cleared and CE-marked third-party AI diagnostic tools. CardiaX Intelligence itself does not constitute a medical device. Each integrated modality carries its own regulatory clearance status. Always verify the regulatory status of specific tools in your jurisdiction before clinical use.

Investigational Notice: ECGio (HEARTio) is INVESTIGATIONAL and NOT FOR SALE IN THE US. CaRi-Heart® (Caristo) is CE-marked; US FDA clearance anticipated 2026. All results must be reviewed and confirmed by a licensed physician. AI outputs are decision-support tools and do not replace clinical judgment.

CPT code 75580 billing support provided for CT-FFR (Keya DeepVessel). Reimbursement is subject to payer policies and physician documentation requirements.

© 2026 CardiaX Intelligence LLC